Approaches to in vitro tissue regeneration with application for human disease modeling and drug development

Reliable in vitro human disease models that capture the complexity of in vivo tissue behaviors are crucial to gain mechanistic insights into human disease and enable the development of treatments that are effective across broad patient populations. The integration of stem cell technologies, tissue e...

Full description

Bibliographic Details
Main Authors: Young, Carissa L., Lauffenburger, Douglas A., Griffith, Linda G., Borenstein, Jeffrey T., Ebrahimkhani, Mohammad Reza
Other Authors: Massachusetts Institute of Technology. Center for Gynepathology Research
Format: Article
Language:en_US
Published: Elsevier 2015
Online Access:http://hdl.handle.net/1721.1/99479
https://orcid.org/0000-0002-8581-1261
https://orcid.org/0000-0002-1801-5548
_version_ 1826203412834811904
author Young, Carissa L.
Lauffenburger, Douglas A.
Griffith, Linda G.
Borenstein, Jeffrey T.
Ebrahimkhani, Mohammad Reza
author2 Massachusetts Institute of Technology. Center for Gynepathology Research
author_facet Massachusetts Institute of Technology. Center for Gynepathology Research
Young, Carissa L.
Lauffenburger, Douglas A.
Griffith, Linda G.
Borenstein, Jeffrey T.
Ebrahimkhani, Mohammad Reza
author_sort Young, Carissa L.
collection MIT
description Reliable in vitro human disease models that capture the complexity of in vivo tissue behaviors are crucial to gain mechanistic insights into human disease and enable the development of treatments that are effective across broad patient populations. The integration of stem cell technologies, tissue engineering, emerging biomaterials strategies and microfabrication processes, as well as computational and systems biology approaches, is enabling new tools to generate reliable in vitro systems to study the molecular basis of human disease and facilitate drug development. In this review, we discuss these recently developed tools and emphasize opportunities and challenges involved in combining these technologies toward regenerative science.
first_indexed 2024-09-23T12:36:11Z
format Article
id mit-1721.1/99479
institution Massachusetts Institute of Technology
language en_US
last_indexed 2024-09-23T12:36:11Z
publishDate 2015
publisher Elsevier
record_format dspace
spelling mit-1721.1/994792022-09-28T08:55:33Z Approaches to in vitro tissue regeneration with application for human disease modeling and drug development Young, Carissa L. Lauffenburger, Douglas A. Griffith, Linda G. Borenstein, Jeffrey T. Ebrahimkhani, Mohammad Reza Massachusetts Institute of Technology. Center for Gynepathology Research Massachusetts Institute of Technology. Department of Biological Engineering Ebrahimkhani, Mohammad Reza Young, Carissa L. Lauffenburger, Douglas A. Griffith, Linda G. Reliable in vitro human disease models that capture the complexity of in vivo tissue behaviors are crucial to gain mechanistic insights into human disease and enable the development of treatments that are effective across broad patient populations. The integration of stem cell technologies, tissue engineering, emerging biomaterials strategies and microfabrication processes, as well as computational and systems biology approaches, is enabling new tools to generate reliable in vitro systems to study the molecular basis of human disease and facilitate drug development. In this review, we discuss these recently developed tools and emphasize opportunities and challenges involved in combining these technologies toward regenerative science. National Institute for Biomedical Imaging and Bioengineering (U.S.) (Grant 5R01EB010246-02) National Center for Advancing Translational Sciences (U.S.) (Grant 1UH2TR000496) United States. Defense Advanced Research Projects Agency (Cooperative Agreement W911NF-12-2-0039) 2015-10-27T17:40:25Z 2015-10-27T17:40:25Z 2014-05 Article http://purl.org/eprint/type/JournalArticle 13596446 http://hdl.handle.net/1721.1/99479 Ebrahimkhani, Mohammad R., Carissa L. Young, Douglas A. Lauffenburger, Linda G. Griffith, and Jeffrey T. Borenstein. “Approaches to in Vitro Tissue Regeneration with Application for Human Disease Modeling and Drug Development.” Drug Discovery Today 19, no. 6 (June 2014): 754–762. https://orcid.org/0000-0002-8581-1261 https://orcid.org/0000-0002-1801-5548 en_US http://dx.doi.org/10.1016/j.drudis.2014.04.017 Drug Discovery Today Creative Commons Attribution-Noncommercial-Share Alike http://creativecommons.org/licenses/by-nc-sa/4.0/ application/pdf Elsevier PMC
spellingShingle Young, Carissa L.
Lauffenburger, Douglas A.
Griffith, Linda G.
Borenstein, Jeffrey T.
Ebrahimkhani, Mohammad Reza
Approaches to in vitro tissue regeneration with application for human disease modeling and drug development
title Approaches to in vitro tissue regeneration with application for human disease modeling and drug development
title_full Approaches to in vitro tissue regeneration with application for human disease modeling and drug development
title_fullStr Approaches to in vitro tissue regeneration with application for human disease modeling and drug development
title_full_unstemmed Approaches to in vitro tissue regeneration with application for human disease modeling and drug development
title_short Approaches to in vitro tissue regeneration with application for human disease modeling and drug development
title_sort approaches to in vitro tissue regeneration with application for human disease modeling and drug development
url http://hdl.handle.net/1721.1/99479
https://orcid.org/0000-0002-8581-1261
https://orcid.org/0000-0002-1801-5548
work_keys_str_mv AT youngcarissal approachestoinvitrotissueregenerationwithapplicationforhumandiseasemodelinganddrugdevelopment
AT lauffenburgerdouglasa approachestoinvitrotissueregenerationwithapplicationforhumandiseasemodelinganddrugdevelopment
AT griffithlindag approachestoinvitrotissueregenerationwithapplicationforhumandiseasemodelinganddrugdevelopment
AT borensteinjeffreyt approachestoinvitrotissueregenerationwithapplicationforhumandiseasemodelinganddrugdevelopment
AT ebrahimkhanimohammadreza approachestoinvitrotissueregenerationwithapplicationforhumandiseasemodelinganddrugdevelopment